Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jun;3(2):80-6.
doi: 10.1007/s11552-007-9071-1. Epub 2007 Sep 11.

Revised Tubiana's staging system for assessment of disease severity in Dupuytren's disease-preliminary clinical findings

Affiliations

Revised Tubiana's staging system for assessment of disease severity in Dupuytren's disease-preliminary clinical findings

Sandip Hindocha et al. Hand (N Y). 2008 Jun.

Abstract

There are few objective staging systems to assess severity of Dupuytren's disease (DD). Previous methods to assess severity of DD were based primarily on the degree of contracture of an affected digit measured using a goniometer. Nonetheless, this method of assessment alone may be incomplete, and other factors should be considered. White (n = 92) patients diagnosed with DD from northwest of England were assessed for DD. Objective criteria for evaluating severity incorporated quantified variables. The revised severity stage was correlated to a known staging system of DD (Tubiana's staging system) which measures total flexion deformity for a single affected digit. Total revised severity staging scores ranged between 4 and 53 (mean = 18.7) and revealed significant positive correlation to Tubiana's original staging system (r (2) = 0.8, p < 0.001). There was significant difference between severity staging scores in those with a positive family history compared to those without (p < 0.01). In current practice, often, the degree of contracture in an affected digit is used solely as a measure of disease severity. Additional objective clinical information may provide useful prognostic indices for disease progression as well as postoperative outcome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Observational findings of 80 men and 12 women with DD.
Figure 2
Figure 2
Correlation of original DD staging system introduced by Tubiana [30] with the revised staging system, for analysis the original stage that is incorporated in the revised staging system is executed.
Figure 3
Figure 3
Correlation of frequency of number of surgical procedures to the revised DD Tubiana staging system, for analysis the frequency of surgical procedures is excluded from the revised DD stage.

Similar articles

Cited by

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15336743', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15336743/'}]}
    2. Abe Y, Rokkaku S, Ofuchi S, Tokunaga S, Takahashi K, Moriya H. An objective method to evaluate the risk of recurrence and extension of Dupuytren’s disease. J Hand Surg (Br) 2004;29-B(5):427–30. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15142693', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15142693/'}]}
    2. Abe Y, Rokkaku S, Ofuchi S, Tokunaga S, Takahashi K, Moriya H. Surgery for Dupuytren’s disease in Japanese patients and a new preoperative classification. J Hand Surg (Br) 2004;29-B(3):233–7. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '6747420', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/6747420/'}]}
    2. Arafa M, Steingold RF, Noble J. The incidence of Dupuytren’s disease in patients with rheumatoid arthritis. J Hand Surg (Br) 1984;9-B:165–6. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '8697659', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8697659/'}]}
    2. Arkkila PE, Kantola IM, Viikari JS, Ronnemaa T, Vahatalo MA. Dupuytren’s disease in type I diabetic patients: a five year prospective study. Clin Exp Rheumatol 1996;14:59–65. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '9002027', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9002027/'}]}
    2. Arkkila PE, Kantola IM, Viikari JS. Dupuytren’s disease: association with chronic diabetic complications. J Rheumatol 1997;24:153–9. - PubMed

LinkOut - more resources